Activist Saba Capital Intensifies Proxy Fight, Details Case for Board Change at BNY Mellon Strategic Municipals
summarizeSummary
Activist investor Saba Capital has filed additional proxy materials, detailing its arguments for electing its nominee, Paul Kazarian, to the board of BNY Mellon Strategic Municipals, Inc. to address persistent trading discounts and governance issues.
check_boxKey Events
-
Activist Proxy Contest Intensifies
Saba Capital, a 10% owner, filed additional definitive materials to support its proxy contest to elect Paul Kazarian to the board.
-
Criticism of Fund Performance & Governance
Saba argues the fund has persistent trading discounts to NAV, high fees, classified board structures, long-tenured and over-boarded directors, and a lack of director stock ownership.
-
Proposed Strategic Changes
Saba's nominee, if elected, would explore options such as merging the fund into an open-ended fund to address discounts and high expenses, citing a successful precedent.
-
Call to Action for Shareholders
The filing urges shareholders to vote for Paul Kazarian using Saba's GOLD proxy card.
auto_awesomeAnalysis
This filing from Saba Capital Management, a 10% owner, escalates its proxy contest by providing a comprehensive presentation outlining the rationale for electing its nominee, Paul Kazarian, to the board. Saba highlights the fund's persistent trading discounts to NAV, high expense ratios, and what it views as problematic governance structures, including classified boards, long-tenured directors, and a lack of director alignment with shareholders. The activist proposes exploring a merger into an open-ended fund to unlock shareholder value, citing a precedent set by BNY Mellon itself. This detailed campaign puts significant pressure on the current board and management to address shareholder concerns and could lead to material changes in the fund's structure and operations.
At the time of this filing, LEO was trading at $6.45 on NYSE in the Unknown sector, with a market capitalization of approximately $401.2M. The 52-week trading range was $5.71 to $6.55. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.